메뉴 건너뛰기




Volumn 7, Issue 6, 2006, Pages 661-668

Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease

Author keywords

Inhibitory kappa B kinases (IKK); Neutrophils; Phosphorylation; Posttranslational modification; Proinflammatory mediators

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ASCORBIC ACID; BMS 34554; BMS 345541; BORTEZOMIB; COMPLEMENTARY RNA; CYCLOPENTENONE DERIVATIVE; DNA; ENZYME INHIBITOR; GENE PRODUCT; I KAPPA B; I KAPPA B KINASE; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROSTAGLANDIN DERIVATIVE; PROTEASOME; SALICYLATE SODIUM; SC 514; SILIBININ; SMALL INTERFERING RNA; THALIDOMIDE; TRANSCRIPTION FACTOR RELA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

EID: 33744825413     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945006777435317     Document Type: Review
Times cited : (69)

References (102)
  • 4
    • 0036234459 scopus 로고    scopus 로고
    • Ghosh, S. and Karin, M. (2002) Cell 109(2, Suppl. 1), S81.
    • (2002) Cell , vol.109 , Issue.2 SUPPL. 1
    • Ghosh, S.1    Karin, M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.